679 Pharmacological Validation of a Mouse Model of Atopic Dermatitis Induced by Topical Calcipotriol

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.755
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparison of Topical Tofacitinib and 0.1% Hypochlorous Acid in a Murine Atopic Dermatitis Model

BMC pharmacology & toxicology
MedicinePharmacology
2018English

Treatment of Vitiligo by Topical Calcipotriol

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2002English

Intrathecal Minocycline Suppresses Itch-Related Behavior and Improves Dermatitis in a Mouse Model of Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Melatonin Inhibits Attention-Deficit/Hyperactivity Disorder Caused by Atopic Dermatitis-Induced Psychological Stress in an NC/Nga Atopic-Like Mouse Model

Scientific Reports
Multidisciplinary
2018English

The Use of Topical Calcineurin Inhibitors in Atopic Dermatitis

Open Dermatology Journal
Dermatology
2014English

Modulation of Experimental Atopic Dermatitis by Topical Application of Gami-Cheongyeul-Sodok-Eum

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2013English

Process Utilities for Topical Treatment in Atopic Dermatitis

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2019English

Lack of Interleukin-33 and Its Receptor Does Not Prevent Calcipotriol-Induced Atopic Dermatitis-Like Inflammation in Mice

Scientific Reports
Multidisciplinary
2020English

Pss61 - Process Utilities for Topical Treatment in Atopic Dermatitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy